Table 2.
Disease | n |
% Response |
Overall survival | ||
---|---|---|---|---|---|
CHR |
Cytogenetic response |
||||
Major | Complete | ||||
CML Chronic | 321 | 77 | 57 | 41 | 91% (18 months) |
CML Accelerated | 136 | 26 | 31 | 19 | 81% (12 months) |
CML Blastic | 136 | 11 | 40 | 29 | 42% (12 months) |
Abbreviations: CHR, complete hematologic response; CML, chronic myeloid leukemia.